Literature DB >> 31797064

How do we sense phosphate to regulate serum phosphate level?

Seiji Fukumoto1, Yuichi Takashi2,3, Maria K Tsoumpra2,4, Shun Sawatsubashi2, Toshio Matsumoto2.   

Abstract

Abnormal phosphate levels result in several pathological conditions such as rickets/osteomalacia and ectopic calcification indicating that there must be a system that regulates phosphate level within a narrow range. FGF23 has been shown to be an essential hormone regulating serum phosphate level. FGF23 binds to Klotho-FGF receptor complex to reduce serum phosphate level. Several reports suggested that FGF receptor is involved in the regulation of FGF23 production. It has been also shown that high extracellular phosphate can activate several intracellular signaling pathways. However, it has been unclear whether and how phosphate regulates FGF23 production in vivo. Our recent results indicate that high extracellular phosphate directly activates FGF receptor 1 and the downstream intracellular signaling enhances FGF23 production. Thus, there is a negative feedback system for the regulation of serum phosphate level involving FGF receptor and FGF23. We propose that FGF receptor works at least as one of phosphate sensors in the maintenance of serum phosphate level.

Entities:  

Keywords:  FGF receptor; FGF23; Phosphate

Mesh:

Substances:

Year:  2019        PMID: 31797064     DOI: 10.1007/s00774-019-01066-0

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  48 in total

1.  Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.

Authors:  Xiuqin Zhang; Omar A Ibrahimi; Shaun K Olsen; Hisashi Umemori; Moosa Mohammadi; David M Ornitz
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

2.  Regulation of fibroblast growth factor-23 signaling by klotho.

Authors:  Hiroshi Kurosu; Yasushi Ogawa; Masayoshi Miyoshi; Masaya Yamamoto; Animesh Nandi; Kevin P Rosenblatt; Michel G Baum; Susan Schiavi; Ming-Chang Hu; Orson W Moe; Makoto Kuro-o
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

3.  Extracellular Phosphate Induces the Expression of Dentin Matrix Protein 1 Through the FGF Receptor in Osteoblasts.

Authors:  Jin Nishino; Miwa Yamazaki; Masanobu Kawai; Kanako Tachikawa; Keiko Yamamoto; Kazuaki Miyagawa; Mikihiko Kogo; Keiichi Ozono; Toshimi Michigami
Journal:  J Cell Biochem       Date:  2017-01-10       Impact factor: 4.429

4.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

Authors:  Yuji Yamazaki; Ryo Okazaki; Minako Shibata; Yukihiro Hasegawa; Kohei Satoh; Toshihiro Tajima; Yasuhiro Takeuchi; Toshiro Fujita; Kazuhiko Nakahara; Takeyoshi Yamashita; Seiji Fukumoto
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

5.  Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway.

Authors:  Masaaki Kimata; Toshimi Michigami; Kanako Tachikawa; Tomoko Okada; Takao Koshimizu; Miwa Yamazaki; Mikihiko Kogo; Keiichi Ozono
Journal:  Bone       Date:  2010-08-13       Impact factor: 4.398

6.  Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.

Authors:  Aline Martin; Shiguang Liu; Valentin David; Hua Li; Anastasios Karydis; Jian Q Feng; L Darryl Quarles
Journal:  FASEB J       Date:  2011-04-20       Impact factor: 5.191

7.  Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Authors:  Kenneth B Jonsson; Richard Zahradnik; Tobias Larsson; Kenneth E White; Toshitsugu Sugimoto; Yasuo Imanishi; Takehisa Yamamoto; Geeta Hampson; Hiroyuki Koshiyama; Osten Ljunggren; Koichi Oba; In Myung Yang; Akimitsu Miyauchi; Michael J Econs; Jeffrey Lavigne; Harald Jüppner
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

8.  Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23.

Authors:  Isao Matsui; Tatsufumi Oka; Yasuo Kusunoki; Daisuke Mori; Nobuhiro Hashimoto; Ayumi Matsumoto; Karin Shimada; Satoshi Yamaguchi; Keiichi Kubota; Sayoko Yonemoto; Tomoaki Higo; Yusuke Sakaguchi; Yoshitsugu Takabatake; Takayuki Hamano; Yoshitaka Isaka
Journal:  Kidney Int       Date:  2018-05-08       Impact factor: 10.612

9.  Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis.

Authors:  Yasushi Oshima; Toru Akiyama; Atsuhiko Hikita; Mitsuyasu Iwasawa; Yuichi Nagase; Masaki Nakamura; Hidetoshi Wakeyama; Naohiro Kawamura; Toshiyuki Ikeda; Ung-il Chung; Lothar Hennighausen; Hiroshi Kawaguchi; Kozo Nakamura; Sakae Tanaka
Journal:  J Biol Chem       Date:  2008-07-16       Impact factor: 5.157

10.  FGFR3 and FGFR4 do not mediate renal effects of FGF23.

Authors:  Shiguang Liu; Luke Vierthaler; Wen Tang; Jianping Zhou; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2008-08-27       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.